Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current EvidenceMara Bacchiani, Andrea Mari, Riccardo Mariottini et al.|Cancers|2023Cited by 23
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Laura S. Mertens, Josef Fritz et al.|The Oncologist|2024Cited by 9